Page last updated: 2024-09-05

bd 1047 and Facial Pain

bd 1047 has been researched along with Facial Pain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roh, DH; Yoon, SY1
Kang, SY; Kim, HC; Kim, HW; Roh, DH; Yoon, SY1

Other Studies

2 other study(ies) available for bd 1047 and Facial Pain

ArticleYear
Sigma-1 receptor antagonist, BD1047 reduces nociceptive responses and phosphorylation of p38 MAPK in mice orofacial formalin model.
    Biological & pharmaceutical bulletin, 2014, Volume: 37, Issue:1

    Topics: Analgesics; Animals; Disease Models, Animal; Ethylenediamines; Facial Pain; Formaldehyde; Lip; Male; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-fos; Receptors, sigma; Sigma-1 Receptor; Signal Transduction

2014
Clonidine Reduces Nociceptive Responses in Mouse Orofacial Formalin Model: Potentiation by Sigma-1 Receptor Antagonist BD1047 without Impaired Motor Coordination.
    Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:9

    Topics: Adrenergic alpha-2 Receptor Agonists; Analgesics; Animals; Blood Pressure; Clonidine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Ethylenediamines; Facial Pain; Formaldehyde; Male; Mice, Inbred C57BL; Pain Measurement; Psychomotor Performance; Receptors, sigma; Rotarod Performance Test; Sigma-1 Receptor

2015